Kimberly Negrin

Kimberly Negrin, Ph.D., is an accomplished leader in the biopharmaceutical industry with extensive experience in business development and commercial strategy, particularly in cell and gene therapy. Currently serving as Director of Business Development at Catalent Pharma Solutions since April 2024, Negrin previously held roles such as Senior Vice President of Commercial at Nucleus Biologics and Business Unit Leader at Stoic Bio, where responsibilities included commercializing innovative technologies and establishing independent business operations. With a background that includes senior roles at Charles River Laboratories and HemaCare Corporation, Negrin has a proven record of driving revenue growth and developing strategic initiatives. Negrin holds a Ph.D. in Immunometabolism from UMass Chan Medical School and a BS in Chemistry and Biology from Slippery Rock University.